Literature DB >> 18441273

Stability and change in patient preferences and spouse substituted judgments regarding dialysis continuation.

Rachel A Pruchno1, Michael J Rovine, Francine Cartwright, Maureen Wilson-Genderson.   

Abstract

OBJECTIVES: The objective of this study was to examine whether some treatment preferences are more stable than others, how patient preferences and substituted judgments change over time, and whether some people's decisions are more stable than others'.
METHODS: Hypothetical scenarios elicited preferences for dialysis continuation under various health conditions at two points in time. Predictors included initial treatment preference, age, gender, race, education, length of time on dialysis, presence of a living will, and change in patient's health.
RESULTS: Some treatment preferences were more stable than others, and the cause of this stability varied across treatment preferences. Similarity between patient preferences and spouse substituted judgments within couples was low and varied as a function of hypothetical condition. The strongest predictor of treatment preferences at follow-up was initial preference. Age, gender, race, education, length of time on dialysis, presence of a living will, and change in patient's health had limited effects on changes to treatment preferences. DISCUSSION: There is a great deal more stability than change in patient preferences and substituted judgments regarding continuation of dialysis over the course of 1 year. This suggests that if patients have previously expressed preferences it is possible for this to maintain their voice in end-of-life decisions when the patients themselves are unable to express their wishes.

Entities:  

Mesh:

Year:  2008        PMID: 18441273     DOI: 10.1093/geronb/63.2.s81

Source DB:  PubMed          Journal:  J Gerontol B Psychol Sci Soc Sci        ISSN: 1079-5014            Impact factor:   4.077


  7 in total

Review 1.  Stability of end-of-life preferences: a systematic review of the evidence.

Authors:  Catherine L Auriemma; Christina A Nguyen; Rachel Bronheim; Saida Kent; Shrivatsa Nadiger; Dustin Pardo; Scott D Halpern
Journal:  JAMA Intern Med       Date:  2014-07       Impact factor: 21.873

2.  Improving medical decisions for incapacitated persons: does focusing on "accurate predictions" lead to an inaccurate picture?

Authors:  Scott Y H Kim
Journal:  J Med Philos       Date:  2014-02-19

3.  Patient preferences for total knee replacement surgery: Relationship to clinical outcomes and stability of patient preferences over 2 years.

Authors:  Ernest R Vina; Di Ran; Erin L Ashbeck; Said A Ibrahim; Michael J Hannon; Jin J Zhou; C Kent Kwoh
Journal:  Semin Arthritis Rheum       Date:  2016-03-30       Impact factor: 5.532

4.  Stability over time in the preferences of older persons for life-sustaining treatment.

Authors:  Ines M Barrio-Cantalejo; Pablo Simón-Lorda; Adoración Molina-Ruiz; Fátima Herrera-Ramos; Encarnación Martínez-Cruz; Rosa Maria Bailon-Gómez; Antonio López-Rico; Patricia Peinado Gorlat
Journal:  J Bioeth Inq       Date:  2013-01-04       Impact factor: 1.352

5.  Randomized controlled trial of SPIRIT: an effective approach to preparing African-American dialysis patients and families for end of life.

Authors:  Mi-Kyung Song; Sandra E Ward; Mary Beth Happ; Beth Piraino; Heidi S Donovan; Anne-Marie Shields; Mary C Connolly
Journal:  Res Nurs Health       Date:  2009-06       Impact factor: 2.228

6.  Stability of end-of-life preferences in relation to health status and life-events: A cohort study with a 6-year follow-up among holders of an advance directive.

Authors:  Matthijs P S van Wijmen; H Roeline W Pasman; Jos W R Twisk; Guy A M Widdershoven; Bregje D Onwuteaka-Philipsen
Journal:  PLoS One       Date:  2018-12-18       Impact factor: 3.240

Review 7.  Making patient values visible in healthcare: a systematic review of tools to assess patient treatment priorities and preferences in the context of multimorbidity.

Authors:  Dee Mangin; Gaibrie Stephen; Verdah Bismah; Cathy Risdon
Journal:  BMJ Open       Date:  2016-06-10       Impact factor: 2.692

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.